Kush Desai, MD
Vascular & Interventional Radiology · Chicago, ILNPI 1194906560
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.9%), speaking fees and grants — rather than concentrated in one kind of arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.1%. Reporting peaked in 2022 at $287,760 and has fallen 77.0% since, to $66,319 in 2025. Among vascular & interventional radiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 776 payments — averaging $1289.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$232K
- Philips North America LLC$163K
- Boston Scientific$154K
- Penumbra, Inc.$140K
- Medtronic$121K
- W. L. Gore & Associates, Inc.$76K
- plus $116K from 22 others
Across 21 payments — averaging $9426.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vesper Medical$83K
- Boston Scientific$59K
- Bard Peripheral Vascular, Inc.$31K
- Medtronic$15K
- Philips North America LLC$6K
- Asahi Intecc USA, Inc.$4K
Across 1 payment — averaging $0.01 each. An ownership or investment interest held by the physician or an immediate family member.
- Intervene, Inc.$0
What the payments were for
- Consulting fees$529,28253%
- Speaking & faculty fees$378,06538%
- Grants$37,0004%
- Travel & lodging$32,5763%
- Food & beverage$19,2032%
- Education$4,7690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 60 | $231,559 |
| Philips North America LLC | 94 | $162,825 |
| Boston Scientific | 157 | $153,880 |
| Penumbra, Inc. | 85 | $139,522 |
| Medtronic(2 entities) | 154 | $120,591 |
| W. L. Gore & Associates, Inc. | 64 | $76,141 |
| Tactile Systems Technology Inc | 33 | $39,342 |
| Bard Peripheral Vascular, Inc. | 26 | $29,208 |
| Shockwave Medical, Inc | 11 | $12,700 |
| Terumo Medical Corporation | 8 | $12,118 |
| Siemens Medical Solutions USA, Inc. | 2 | $6,140 |
| Cook Medical LLC | 48 | $5,018 |
| Cordis US CORP. | 3 | $2,501 |
| Servier Affaires Medicales | 1 | $2,152 |
| Abbott | 3 | $1,406 |
| Asahi Intecc USA, Inc. | 3 | $1,289 |
| Surmodics, Inc. | 3 | $1,275 |
| Vesper Medical | 2 | $1,023 |
| Argon Medical Devices, Inc. | 5 | $652 |
| Cardinal Health 200 LLC | 3 | $537 |
| Mercator Medsystems, Inc. | 2 | $474 |
| Inari Medical, Inc. | 1 | $195 |
| Avantec Vascular Corporation | 2 | $138 |
| Kerecis Limited | 2 | $136 |
| Organogenesis Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $17 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$122,970
- Abre$103,173
- Product in Development$74,317
- (9520) IGT Devices Undivided$72,182
- Zilver Vena$47,202
- ELCA$36,000
- GENERAL VASCULAR INTERVENTION$35,229
- Flexitouch Plus$29,873
- ENTRE$25,343
- Cook Medical Stents$22,733
- GENERAL - THERAPIES$21,094
- EKOSONIC$19,189
- GlideLight$18,960
- Lunderquist$18,784
- (6554) Peripheral Vascular Undivided$15,449
- RUBY Coil$11,600
- (6554) Periph Vasc Undiv$10,500
- FLEXITOUCH$9,158
- ACTITOUCH$9,158
- Vascular Lithotripsy$9,000
How this compares
$1,000,896 in reported general payments places this provider in the 95th percentile of 197 vascular & interventional radiology providers in Illinois.
See all vascular & interventional radiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $56,092 |
| Enoxaparin Sodium | 14 | $8,645 |
| Methylprednisolone | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Chicago
- Riad SalemChicago$2.3M
- Robert LewandowskiChicago$954K
- Christopher MolvarChicago$850K
- Sreekumar MadasseryChicago$459K
- Bulent ArslanChicago$300K
- Sameer AnsariChicago$161K
- Ahsun RiazChicago$127K
- Ramona GuptaChicago$72K
- Scott ResnickChicago$38K
- Erica AlexanderChicago$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.